Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Benefit of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in the Treatment Algorithm of Staphylococcus Aureus Bacteremia

NCT02476487 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT02476487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02476487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Benefit of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in the Treatment Algorithm of Staphylococcus Aureus Bacteremia
Lead sponsor
Rambam Health Care Campus
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2015
Completion date
December 31, 2021
Enrollment
143 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcus aureus bacteremia